237 related articles for article (PubMed ID: 38059844)
21. Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications.
Yamagami F; Tajiri K; Yumino D; Ieda M
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614923
[TBL] [Abstract][Full Text] [Related]
22. Indoxyl Sulfate, a Uremic Endotheliotoxin.
Lano G; Burtey S; Sallée M
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
[TBL] [Abstract][Full Text] [Related]
23. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
[TBL] [Abstract][Full Text] [Related]
24. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
[TBL] [Abstract][Full Text] [Related]
25. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.
Di Paola R; De A; Izhar R; Abate M; Zappavigna S; Capasso A; Perna AF; La Russa A; Capasso G; Caraglia M; Simeoni M
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372437
[TBL] [Abstract][Full Text] [Related]
26. Uremic Toxins and Vascular Dysfunction.
Six I; Flissi N; Lenglet G; Louvet L; Kamel S; Gallet M; Massy ZA; Liabeuf S
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32570781
[TBL] [Abstract][Full Text] [Related]
27. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
28. Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.
Drew DA; Weiner DE; Sarnak MJ
Am J Kidney Dis; 2019 Dec; 74(6):782-790. PubMed ID: 31378643
[TBL] [Abstract][Full Text] [Related]
29. Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
Nakagawa T; Hasegawa Y; Uekawa K; Kim-Mitsuyama S
Exp Gerontol; 2017 Jan; 87(Pt A):108-112. PubMed ID: 27916702
[TBL] [Abstract][Full Text] [Related]
30. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
31. Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.
Shih YC; Wu CC; Wang SC; Liou JY; Huang PH; Tarng DC
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32276394
[TBL] [Abstract][Full Text] [Related]
32. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
33. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
Filipska I; Winiarska A; Knysak M; Stompór T
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
[TBL] [Abstract][Full Text] [Related]
34. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Black AP; Cardozo LF; Mafra D
Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
[TBL] [Abstract][Full Text] [Related]
35. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
36. Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: neuroprotective effect of tempol.
Fujisaki K; Tsuruya K; Yamato M; Toyonaga J; Noguchi H; Nakano T; Taniguchi M; Tokumoto M; Hirakata H; Kitazono T
Nephrol Dial Transplant; 2014 Mar; 29(3):529-38. PubMed ID: 24030834
[TBL] [Abstract][Full Text] [Related]
37. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
[TBL] [Abstract][Full Text] [Related]
39. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?
Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D
Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817
[TBL] [Abstract][Full Text] [Related]
40. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
